Posttransplant Lymphoproliferative Disease after Lung Transplantation

Posttransplant lymphoproliferative disease (PTLD) after lung transplantation occurs due to immunosuppressant therapy which limits antiviral host immunity and permits Epstein-Barr viral (EBV) replication and transformation of B cells. Mechanistically, EBV survives due to latency, escape from cytotoxi...

Descripción completa

Detalles Bibliográficos
Autor principal: Neuringer, Isabel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603163/
https://www.ncbi.nlm.nih.gov/pubmed/23533455
http://dx.doi.org/10.1155/2013/430209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603163/
https://www.ncbi.nlm.nih.gov/pubmed/23533455
http://dx.doi.org/10.1155/2013/430209

Ejemplares similares